Nucleic Acid-Conjugated Polymeric Nanoparticles for Gene Therapy
A nanoparticle composition including: a first polymer conjugated to a drug by a linker to form a first polymer compound, the first polymer compound having a net negative charge; and a second polymer conjugated to at least one positively charged group to form a second polymer compound, the second polymer compound having a net positive charge, and the first polymer compound and the second polymer compound interacting electrostatically to form a nanoparticle.
Researchers
-
nucleic acid-conjugated polymeric nanoparticles and methods of use
European Patent Convention | Published application -
nucleic acid-conjugated polymeric nanoparticles and methods of use
United States of America | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.